Concepedia

A.F. Navarro Mendivil

AN

2

Publications

21

Citations

2

H-Index

2023

Active since

Affiliations

Hebron University(Current)

Vall d'Hebron Hospital Universitari

A.F. Navarro Mendivil is an author at Hebron University.

Publications per year

2023–2024

2

Publications

2

LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial

S. Senan, David R. Spigel, Byoung Chul Cho et al. · Annals of Oncology · 2024 · 11 citations · Full text

1989MO Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study

Antonio Calles, A.F. Navarro Mendivil, B. Doger de Spéville et al. · Annals of Oncology · 2023 · 10 citations · Full text

Rows per page

1–2 of 2